Maximus · 10 hours ago
Senior Technical Surveillance Countermeasures (TSCM) Analyst
Maximus is seeking a Technical Surveillance Countermeasures Professional for national security operational requirements. The role involves establishing internal capabilities to assess and mitigate technical and physical security concerns, conducting various assessments, and providing technical security expertise.
Business Process Automation (BPA)ConsultingEducationGovernmentGovTechHealth CareInformation Technology
Responsibilities
Develop, implement, and maintain TSCM programs and capabilities
Conduct physical/technical assessments to identify vulnerabilities and recommend mitigation
Conduct Technical Surveillance Countermeasures inspections
Conduct TEMPEST surveys/assessments and recommend mitigations
Conduct acoustic testing to determine ICD 705 waiver requirements
Research and development of policy and instruction at Agency and ICD level
Evaluate and recommend medical device approval or mitigation strategy
Conduct radio frequency direction finding mission to identify unauthorized transmitting devices
Provide technical security SME input to designated IC working groups
Develop and dissemination of workforce education for CI and Sec
Qualification
Required
Active TS/SCI with Polygraph
BA degree and 12+ years of prior relevant experience or Masters with 10+ years of prior relevant experience
TSCM Certified with experience of TEMPEST assessments
Expert level of knowledge of Radio Frequencies, direction finding procedures, wireless communications, and general TSCM procedures and processes
General knowledge of counterintelligence investigations, insider threat operations, physical security and anti-terrorism requirements, cyber security, digital forensic and IT infrastructure
Minimum 5 years working with or in the IC
Benefits
Health insurance coverage
Life and disability insurance
A retirement savings plan
Paid holidays
Paid time off
Company
Maximus
Providing government technology services, digitally enabled customer experiences, and clinical health services that change lives.
Funding
Current Stage
Public CompanyTotal Funding
$7.93M2010-12-09Post Ipo Equity· $7.93M
Leadership Team
Recent News
2025-11-20
Company data provided by crunchbase